In a new blog post and guest editorial by Dr. Alicia Wise, Director of Universal Access at Elsevier, offers a look what the new year will bring for open access at Elsevier. Her blog post was derived from a guest editorial in The Journal of Academic Librarianship (full-text available, free).
From Alicia Wise’s Blog Post:
This year, we will continue to add to our list of more than 31 open access titles. To start this off, we have already launched two new titles in January: Stem Cell Reports — the result of collaboration between Cell Press and the International Society for Stem Cell Research — and the Journal of Pediatric Surgery Case Reports.
In addition to open access journals, we now also offer authors the option to make their article open access in 1,500 hybrid journals. This makes it even easier for authors to choose either after acceptance or retrospectively after publication. All our hybrid journals now have an open access options logo making it easier to identify where authors can publish open access.
We remain committed to our other universal access initiatives, of course, such as enhancing access to our content in developing countries through our continued participation in the Research4Life program. Currently, we are providing access to over 2,000 journals and 6,000 books. Check out the new case studies to read more about the impact of such contributions.
…while Elsevier believes that the subscription model will remain popular among our customers, the company is well-prepared to scale up our open access publishing as this becomes more important to researchers. We have the global reach and technology to offer these publishing services efficiently and we are committed to working with all stakeholders to help ensure that open access policies are implemented in a way that is economically viable. Our dedication to access extends beyond publishing models as well. For example, we support technologies so people with disabilities can read our content, we provide text and data mining services, and we offer various access options for patients and other purchasers. We refer to this spectrum of activities, and the vision of access-for-all which underpins it, as universal access.